Evidence map›Paper›PMID 35889298›Full record

ArticleMolecules (Basel, Switzerland)2022

Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.

Tayel A Al Hujran, Mousa K Magharbeh, Almeqdad Y Habashneh, Rasha S Al-Dmour, Ashraf Aboelela, Hesham M Tawfeek

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Tayel A Al HujranThe Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
Mousa K MagharbehThe Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
Almeqdad Y HabashnehThe Department of Chemistry, School of Science, The University of Jordan, Amman 11942, Jordan.
Rasha S Al-DmourThe Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
Ashraf AboelelaThe Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sphinx University, Assiut 71515, Egypt.
Hesham M TawfeekIndustrial Pharmacy Department, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.ORCID 0000-0001-9789-9953
Mutah University · JOAssiut University · EGSphinx University · EGUniversity of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aims to assess the interaction between fluconazole and sulfonatocalix[4]naphthalene towards enhancing its dissolution performance and antimycotic activity. A solubility study was carried out at different pH conditions, and the results revealed the formation of a 1:1 molar ratio fluconazole-sulfonatocalix[4]naphthalene inclusion complex with an A

Indexed as

beta-CyclodextrinsFluconazoleCalorimetry, Differential ScanningNaphthalenesPowdersSolubilitySpectroscopy, Fourier Transform InfraredX-Ray Diffractionbeta-CyclodextrinsFluconazoleNaphthalenesPowdersantimycotic activitydissolution ratefluconazoleinclusion complexationphase solubilitysulfonatocalix[4]naphthalene

Identifiers

PMID35889298
PMCPMC9317573
OpenAlexW4285094584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.